Mirum Pharmaceuticals (MIRM) Gross Margin (2021 - 2026)
Mirum Pharmaceuticals' Gross Margin came in at 81.06% for Q3 2026, up 0.26 percentage points from 80.80% a year earlier but down 1.72 percentage points from the prior quarter.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Gross Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Mirum Pharmaceuticals reported Gross Margin of 81.72%, up 1.81 percentage points year-over-year; for FY2025, it was 80.77%, up 5.01 percentage points from FY2024.
- Gross Margin carries a four-year change of -9.28 percentage points (FY2021 to FY2025).
- Going back by year, Gross Margin was 75.77% in FY2024 (+1.00 pp), 74.76% in FY2023 (-9.18 pp), 83.94% in FY2022 (-6.11 pp) and 90.06% in FY2021.
- The five-year range for quarterly Gross Margin is 39.36% (Q4 2021) to 85.56% (Q2 2022).
- Year-over-year, Gross Margin has increased for eight consecutive quarters, with an average year-over-year change of +4.70 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q4 2022 (a gain of 44.54 percentage points), and the weakest in Q4 2023 (a drop of 19.87 percentage points).
- Business Quant data shows MIRM's Gross Margin at 82.78% (Q2 2026), 81.98% (Q1 2026) and 81.02% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 75.71% |
| 10 | Mirum Pharmaceuticals | 6.06 Bn | 4.48 Bn | 150.55 Mn | 81.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 81.06% |
| Jun 30, 2026 | 82.78% |
| Mar 31, 2026 | 81.98% |
| Dec 31, 2025 | 81.02% |
| Sep 30, 2025 | 80.80% |
| Jun 30, 2025 | 81.67% |
| Mar 31, 2025 | 79.37% |
| Dec 31, 2024 | 77.09% |
| Sep 30, 2024 | 76.98% |
| Jun 30, 2024 | 74.03% |
| Mar 31, 2024 | 74.24% |
| Dec 31, 2023 | 64.03% |
| Sep 30, 2023 | 78.57% |
| Jun 30, 2023 | 81.83% |
| Mar 31, 2023 | 84.24% |
| Dec 31, 2022 | 83.90% |
| Sep 30, 2022 | 84.39% |
| Jun 30, 2022 | 85.56% |
| Mar 31, 2022 | 81.20% |
| Dec 31, 2021 | 39.36% |
API Access
Mirum Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=MIRM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();